Sellas Life Sciences: A Hold For Now With Huge, But Uncertain, Near-Term Catalyst
Sellas Life Sciences Group, Inc.'s Phase 3 GPS trial sparks uncertainty; stock's a Hold. Interim results for GPS are ...